Search
Selected Filter
Filter Results
Displaying 1–10 of 559 news results
-
Apr 14, 2026
Usher Syndrome Research Advances
Research NewsRecent developments in research on Usher Syndrome.
-
Apr 14, 2026
Stargardt Disease Research Advances
Research NewsRecent developments in research on Stargardt disease.
-
Apr 14, 2026
Age-Related Macular Degeneration Research Advances
Research NewsRecent developments in research on age-related macular degeneration.
-
Apr 14, 2026
Leber Congenital Amaurosis Research Advances
Research NewsRecent developments in research on Leber congenital amaurosis.
-
Apr 14, 2026
Retinitis Pigmentosa Research Advances
Research NewsRecent developments in research on retinitis pigmentosa.
-
Apr 8, 2026
Opus Genetics Secures $155 Million Financing to Accelerate Gene Therapy Pipeline
Research NewsStrategic funding extends cash runway through 2029 and advances multiple inherited retinal disease programs
-
Apr 8, 2026
Illuminating the Future: Highlights from Investing in Cures Summit 2026
Foundation NewsAt ICS 2026 in Boston, leading researchers, clinicians, and industry pioneers shared the latest advances in gene therapy, precision genetic medicine, and gene-agnostic approaches for inherited retinal diseases.
-
Apr 7, 2026
Recording Available: Insights Forum | Thursday, March 26, 2026
Foundation NewsThe Foundation Fighting Blindness is pleased to provide a recording and full transcript of the Insights Forum, our quarterly conference call providing updates to the blinding diseases community. The call took place on March 26, 2026.
-
Mar 26, 2026
VeonGen Reports Promising Clinical Progress for Stargardt Disease Gene Therapy
Research NewsVG801 shows sustained vision improvements through 12 months with favorable safety profile
-
Mar 24, 2026
Sumitomo Pharma Receives FDA Orphan Drug Designation for Retinitis Pigmentosa Treatment
Research NewsPotential cell therapy, DSP-3077, gains special regulatory status to support development for inherited retinal disease.